M. Granatkin

Azacitidine/Venetoclax Combination as First-Line Therapy in Elderly Patients with Acute Myeloid Leukemias: A First Step

V. Doronin, V. Ptushkin, S. A. Lugovskaya, 2022, Clinical oncohematology.

Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience

V. Doronin, V. Ptushkin, S. A. Lugovskaya, 2023, Oncohematology.